Auriga, a custom software development services provider, will participate in the European Medical Device & Diagnostic Strategic Product Development Virtual Conference on May 25–27, 2021. The event will feature 150+ medtech companies, 16+ distinguished speakers, 20+ solution-focused sessions, and six roundtable discussions with 100% remote access.
The 2021 European Medical Device and Diagnostic Strategic Product Development Virtual Conference will focus on the challenges medtech manufacturers face in today’s post-Covid-19 environment. The topics will include streamlining product and prototype development processes, best design and testing practices, EU MDR compliance, and risk mitigation throughout the development cycle.
The conference will also cover the latest innovations in the medtech industry: integrating a flexible prototyping process by utilizing AR and 3D printing; AI and machine learning application in diagnostics, therapeutics, and automation; next-gen technologies, including miniaturization, wearables, and implantables; digital transformation in healthcare; and more.
Andrey Shastin, Auriga’s Head of Global Business Development in the medical and embedded systems domains, commented:
Given Auriga’s strategic focus on medical device software development, we cannot miss the opportunity to attend a dedicated conference for medtech product development professionals. We look forward to engaging in collaborative discussions, learning from our industry peers, and sharing our own hands-on experience. I believe we will benefit from the virtual conference format.
Auriga boasts 18+ years of medical software development and testing experience, and it has repeatedly been acknowledged by both customers and industry experts, such as the IAOP®. The company is ISO 13485 certified and runs eight R&D and testing labs for medical devices in Eastern Europe. Explore our online portfolio of medical device and digital health projects or contact us via the website to get more information on Auriga’s services.
